---
raindrop_id: 729989920
raindrop_highlights:
  65c0cc8749b2c6288128435b: 247f9ac7edd0bf7635a6eb5768dcf888
  65c0ccad697d2fd7e3375f0e: b180e1684f1f3bcbc9e881442cd78220
  65c0f42d9cfb4459a658d6ef: 9eed102a895663b9d30b18080e3d1232
  65c0f439644cde30734cdaf4: d00a2e39150e919a9cf2b7dc386f8c99
  65c0f4506e9bf4a8936f7846: 7e473bf75770b0e96a9f866a5cee750d
  65c0f93a93dca37808a1f9b0: e562c69036fa2bf624a3b5eacece6236
  65c0f9496e9bf4a893705817: 072694ffa45489d3d6b3954e8e3cd699
  65c0f9579cfb4459a659c0f8: 79de59453ea8205d1ccd06f894f3de40
  65c0f97098b28552b10e9ed0: d65bd0a12ca848a6e95e30dcad0e8755
  65c0f97a98b28552b10ea0d0: a1c3ab5a1a78180e60db1b56f918edbd
  65c0f9919cfb4459a659cbad: 4e67f5e56967f286ca76fdd1db10f0ec
  65c0f9b89cfb4459a659d1e7: 5b29fac355e0b4326325e91b0b2591b9
  65c0fa0e93dca37808a21e8f: 7c8c02dcbd35a2d74364090562854445
  65c0fa1c49b2c628812f8ff6: 5c3e60f4c93e7aaaa38337dabc8f7e4a
  65c0fa3d9cfb4459a659e98b: b90482c01b7e453ae2fc0f1cfb388cb6
  65c0fa6698b28552b10ece8f: 55fdb0b34ff3dc6779395323c9f59124
  65c0fa9c49b2c628812fb113: f898873f6e56001ea0a969899dfe3f09
  65c0faaf93dca37808a248e9: 09f9178c504aa73c23cb03e6b679e114
  65c0fab99cfb4459a65a0d95: 577f348f062a3955d3581c6b456b71e1
  65c0faee3761bd605b009505: a8dbbbd6c3411b348e8f18e4524cc0b9
  65c0fb19697d2fd7e33eed17: 6b1791744586b3b9aee24d1f9614c28c
  65c0fb286e9bf4a89370c65c: 14eb2c97611c73751a5454f4e9eea4b9
  65c0fb5a9b19504e3e9b744e: 188229e660f0ff34b6f3a0f25b5b0e4a
  65c0fb6675c9cec0e967f956: decbcba0fa567f78bff4cae53f66e61e
  65c0fb7f644cde30734e44f0: 2c860dddb7280f2570e6d33555848589
  65c0fb8a9cfb4459a65a4868: 02a609be4bcf0b1b3af087c3ae725ea1
  65c0fb9149b2c628812ff631: 533853f9328d4115e2f7e1ff4c1d730a
  65c0fba349b2c628812ffa7c: 849a508723a9d34ca5adc8f7739a3edc
  65c0fbab49b2c628812ffd30: 3f43cfa963fdf508d2d2cec98d63dee3
---

# Metadata
Source URL:: https://link.springer.com/article/10.1007/s44192-022-00030-1


---
# An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder

Discover Mental Health - Attention-Deficit/Hyperactivity Disorder (ADHD) is a prevalent psychiatric condition characterized by developmentally inappropriate symptoms of inattention and/or...

## Highlights

> [!quote]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> A putative pathophysiological mechanism that has been long implicated in ADHD involves the dysregulation of monoaminergic neurotransmission systems, mainly dopaminergic and noradrenergic

> [!quote]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> binding of dopamine and norepinephrine to their respective receptors involve the modulation of several cognitive and executive processes usually impaired in

> [!quote]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> Genetics of ADHD

> [!quote]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> The genetic contribution to ADHD is among the highest for psychiatric disorders

> [!quote]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> The total heritability of ADHD has been estimated at 70–80% [46, 47

> [!quote]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> For adults, some studies, especially those based on self-report measures, describe a drop in heritability estimates

> [!quote]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> studies that used cross-informant data and/or clinical diagnosis report that heritability estimates in adults could be as high as those observed in children, suggesting that phenotype measurement biases could play a larger role than true age-dependent decline [50]

> [!quote]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> available evidence suggests that nonadditive effects (genetic interactions) also contribute to a large proportion of phenotypic variance and that the effects of a shared family environment are minimal [49, 51].

> [!danger]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> Based on these studies, the proportion of the phenotypic variation attributed to common genetic variants (known as h2SNP) has been estimated for ADHD

> [!quote]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> estimated the ADHD h2SNP at ≈22% [52

> [!check]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> n an updated GWAS meta-analysis of ADHD (2022-ADHD), the h2SNP was lower than in the previous GWAS, valued at 14% [53]. The authors attributed this difference to varying ascertainment strategies and designs or lower effective sample sizes on specific individual cohorts that comprised the study

> [!quote]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> Nevertheless, the results indicate that around 7000 common variants can explain 90% of the h2SNP, confirming the extensive polygenic architecture of ADHD and that many hits, in addition to those already discovered, will become significant as the sample size increases

> [!quote]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> The cross-trait genetic correlation is usually estimated using the linkage disequilibrium score regression (LDSC) or the polygenic scores (PGS) approaches

> [!quote]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> These analyses have revealed negative relationships between ADHD and different neurocognitive domains, including attention (beta = − 0.07, P = 3,25E-7) and working memory (beta = − 0.05, P = 2,45E-3) [53

> [!danger]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> On the other hand, ADHD presents positive genetic correlations with other psychiatric disorders (e.g., major depressive disorder (rg = 0.31 to 0.52, P = 2,96E-06 to 2,18E-20), autism spectrum disorder (rg = 0.42, P = 1,19E-18), bipolar disorder (rg = 0.26, P = 7E-6), and schizophrenia (rg = 0.17 to 0.22, P = 1,72E-09 to 1,22E-06) and with other psychiatric-related conditions, such as neuroticism (rg = 0.23 to 0.33, P = 0.0008 to 2,61E-13), symptoms of depression (rg = 0.39 to 0.53, P = 1,25E-6 to 1,63E-32), insomnia (rg = 0.46, p = 3,73E-20), smoking initiation (rg = 0.48, P = 1,78E-11) and cannabis use (rg = 0.29 to 0.61, P = 1,63E-5 to 1,27E-42) [53, 59, 61].

> [!check]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> it is important to notice that there are traits, such as intelligence and cognitive performance, presenting the same direction of association to both ADHD and Alzheimer’s disease, suggesting the possibility of shared traits that contribute to both phenotypes.

> [!info]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> A subsequent study found a similar level of genetic correlation between childhood ADHD and persistent ADHD (rg = 0.82), but lower with late-diagnosed ADHD (rg = 0.65), suggesting this group might present some differences in its genetic architecture when compared to childhood ADHD [

> [!check]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> In this regard, Mendelian Randomization (MR) has been used as a promising approach to investigate potential causal relationships between an exposure (e.g., brain measures or environmental exposures) and an outcome (e.g., ADHD susceptibility) by using genetic variants as instrumental variables

> [!check]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> Since genetic variants are randomly determined at conception, using them as instruments has the potential to eliminate confounding effects behind associations while evaluating causal effects between a risk factor and a clinical phenotype

> [!danger]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> On the other hand, genetics of neurocognitive, such as general intelligence [80,81,82], and brain features (e.g. total brain volume, functional connectivity between the default mode and salience networks [80], and white matter microstructure of anterior limb of internal capsule [83] seem to represent a relevant causal role in ADHD pathogenesis, distinguishing important brain aspects playing etiological roles from those that are simply correlated with or consequences of ADHD

> [!info]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> These findings help to disentangle the previous associations observed in cross-sectional studies, providing insights into the biological mechanisms underlying ADHD pathophysiology that can be useful for the research on potential biomarkers and preventive strategies for ADHD

> [!quote]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> MR relies on major assumptions that when violated can introduce bias to the analyses, especially regarding the absence of horizontal pleiotropy and potential confounders affecting the exposure-outcome relationship

> [!info]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> a curve pattern in an ‘inverted U’ shape, that is, both very intense activity (for example, during stressful situations) and very low activity (for example, states of somnolence) impair the functioning of these systems [90].

> [!info]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> corroborating the monoaminergic hypothesis for ADHD pathophysiology

> [!quote]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> For example, dopamine receptors of subtypes D1 and D2 are abundant in brain regions mainly involved in signaling reward circuits, learning and memory, and locomotor activity [90].

> [!danger]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> patients with ADHD have a higher density of the dopamine transporter (DAT), responsible for the reuptake of DA into presynaptic neurons [92]

> [!danger]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> lead to alterations in dopamine levels in the synaptic cleft

> [!danger]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> The binding of norepinephrine with adrenergic receptors has been shown to modulate working memory processes, for which moderate or high levels of this neurotransmitter present differential binding affinities to each type of receptor and consequently different physiological effects on working memory

> [!danger]+ Updated on Mon Feb 05 2024 23:15:55 GMT+0800
>
> methylphenidate treatment on working memory appear to be dependent on α2 noradrenergic receptors, whereas the improvement in sustained attention involves the α1 subtype [94].
